Journal of Current Glaucoma Practice

Register      Login

VOLUME 11 , ISSUE 3 ( September-December, 2017 ) > List of Articles

ORIGINAL ARTICLE

Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: A One-year Study

Albert S Khouri, Grace Huang, Linda Y Huang

Citation Information : Khouri AS, Huang G, Huang LY. Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: A One-year Study. J Curr Glaucoma Pract 2017; 11 (3):101-106.

DOI: 10.5005/jp-journals-10028-1233

License: CC BY 3.0

Published Online: 01-12-2017

Copyright Statement:  Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim

To determine the safety and efficacy of intraoperative injection of mitomycin C (MMC) against conventional sponge-applied MMC during trabeculectomy.

Materials and methods

This study was a retrospective, comparative case series. Thirty eyes with primary open-angle glaucoma underwent consecutive trabeculectomies with MMC injection (injection group), and thirty eyes with sponge-applied MMC were as controls (sponge group). Data were collected preoperatively and postoperatively at 1 day, 1 week, 1 month, 3 months, 6 months, and 1 year after surgery. Demographic data, applanation intraocular pressure (IOP), best-corrected visual acuity (VA), number of glaucoma medications, postoperative interventions, postoperative complications, and number of visits within 3 months were recorded. In order to stratify data, proportion of eyes achieving >30% IOP reduction from baseline with or without glaucoma medications was calculated and defined as surgical success.

Results

Mean IOP reduction at 1 year was significant in both the injection and sponge groups from baseline (46.8 and 37.8% respectively). The injection group had overall lower postoperative IOP and comparable complete treatment success, defined as achieving >30% IOP reduction without glaucoma medications (p = 0.941). The number of postoperative visits within 3 months and the proportion of eyes needing 5-fluorouracil (5-FU) intervention were significantly lower in the injection group (p = 0.03, p = 0.04 respectively).

Conclusion

Injection of MMC was as safe and effective as sponge application with comparable estimated complete treatment success, less need for visits within 3 months, and 5-FU intervention.

Clinical significance

Surgeons may consider intraoperative injection of MMC in appropriate patient cohorts given comparable safety and efficacy and several advantages over traditional sponge application. Further study in a prospective, larger, long-term manner is necessary to assess this modality.

How to cite this article

Khouri AS, Huang G, Huang LY. Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: A One-year Study. J Curr Glaucoma Pract 2017;11(3):101-106.


  1. Mitomycin-C use in ophthalmology. J Pharm 2013;3(1):12-14.
  2. Uses and complications of mitomycin C in ophthalmology. Expert Opin Drug Saf 2007 Jan;6(1):27-32.
  3. Wound healing and glaucoma surgery: modulating the scarring process with conventional antimetabolites and new molecules. Dev Ophthalmol 2012;50:79-89.
  4. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 2003 May-Jun;48(3):314-346.
  5. Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultrastructural study. Graefes Arch Clin Exp Ophthalmol 1995 Mar;233(3):154-162.
  6. Encapsulated filtering blebs after trabeculectomy with mitomycin-C. Ophthalmic Surg Lasers 1997 Oct;28(10):805-809.
  7. Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev 2001;2(2):28-97.
  8. Long-term results of trabeculectomy with mitomycin C applied under the scleral flap. Int Ophthalmol 2007 Dec;27(6):351-355.
  9. Trabeculectomy; 2011. Accessed 2014 Jun 4. Available from: http://eyewiki.aao.org/Trabeculectomy.
  10. Mitomycin-C needle bleb revision in congenital glaucoma. Middle East Afr J Ophthalmol 2010 Oct;17(4):369-373.
  11. Late needling of flat filtering blebs with adjunctive mitomycin C: efficacy and safety for the corneal endothelium. Ophthalmology 2011 Apr;118(4):755-762.
  12. Prospective evaluation of preoperative factors associated with successful mitomycin C needling of failed filtration blebs. J Glaucoma 2006 Apr;15(2):98-102.
  13. Slit-lamp needle revision of failed filtering blebs using mitomycin C. Ophthalmology 1996 Nov;103(11):1946-1955.
  14. Slit-lamp needle revision of failed filtering blebs using high-dose mitomycin C. J Glaucoma 2005 Feb;14(1):52-56.
  15. Trabeculectomy surgery augmented with intra-Tenon injection of mitomycin C. Acta Ophthalmol 2008 Dec;86(8):866-870.
  16. Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci 1997 Jul;38(8):1639-1646.
  17. Enhancement of the success rate in trabeculectomy: large-area mitomycin-C application. Clin Exp Ophthalmol 2008 May;36(4):316-322.
  18. Rethinking Mitomycin C; 2014. Accessed 2014 Jun 4. Available from: http://www.aao.org/publications/eyenet/200503/feature.cfm.
  19. A comparison of trabeculectomy surgery outcomes with mitomycin-C applied by intra-Tenon injection versus sponge method. American Glaucoma Society 23rd Annual Meeting; 2013, San Francisco, CA.
  20. A novel method for controlling the quantity of mitomycin-C applied during filtering surgery for glaucoma. J Ocul Pharmacol Ther 1998 Dec;14(6):491-496.
  21. Impact of irrigation in a new model for in vitro diffusion of mitomycin-C after episcleral application. Curr Eye Res 2002 Oct;25(4):221-225.
  22. Ocular concentrations of mitomycin C using different delivery devices. Ophthalmologica 1998;212(1):37-42.
  23. A long-term dose-response study of mitomycin in glaucoma filtration surgery. Arch Ophthalmol 1997 Aug;115(8):969-974.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.